Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
740.50
-8.30 (-1.11%)
At close: Mar 27, 2025
-3.79%
Market Cap 1.78B
Revenue (ttm) 226.30M
Net Income (ttm) 9.95M
Shares Out 2.40M
EPS (ttm) 4.15
PE Ratio 178.59
Forward PE n/a
Dividend 1.00 (0.14%)
Ex-Dividend Date Dec 3, 2024
Volume 1,519
Average Volume 796
Open 765.00
Previous Close 748.80
Day's Range 740.00 - 765.00
52-Week Range 650.00 - 1,002.70
Beta -0.33
RSI 49.00
Earnings Date Apr 16, 2025

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal, anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid dr... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 529
Stock Exchange Dhaka Stock Exchange
Ticker Symbol AMBEEPHA
Full Company Profile

Financial Performance

In 2024, Ambee Pharmaceuticals's revenue was 219.30 million, an increase of 10.71% compared to the previous year's 198.10 million. Earnings were 9.68 million, an increase of 6.53%.

Financial Statements

News

There is no news available yet.